ロード中...
Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
BACKGROUND: The previously described and validated Erlangen Score (ES) algorithm enables interpretation of the cerebrospinal fluid (CSF) biomarkers of Alzheimer’s disease (AD), ordering them on an ordinal scale: from neurochemically normal (ES = 0) through improbable AD (ES = 1), possible AD (ES = 2...
保存先:
| 出版年: | Alzheimers Res Ther |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6320577/ https://ncbi.nlm.nih.gov/pubmed/30611311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0456-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|